Description
Achievements:
- Nouvelle classe de molécules antifongiques (ICM < 1 µg/mL)
- Activity against Candida albicans and Candida auris
•Ability to destroy the formed biofilm - Activity against Aspergillus fumigatus
- New target
- Development of an “in vivo-like” model of Galleria mellonella
•No in vitro toxicity
IP: Patent pending